The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Orbimed Capital Gp Viii Llc since 2025.
This trader's CIK number is 1845804.
At the time of last reporting, Orbimed Capital Gp Viii Llc was the Officer of Traws Pharma, Inc.. (stock ticker symbol TRAW).
Also see all insider trading activities at Traws Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | TRAW | 597,729 | $998,207 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | SION | 0 | $0 | 596,881 | $26,797,249 | 0 | $0 |
| 2025 | SION | 550,000 | $9,900,000 | 143,304 | $6,383,640 | 0 | $0 |
2. Sionna Therapeutics, Inc. (SION)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-04-16 | TRAW | Buy | 597,729 | 1.67 | 998,207 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-04-17 | SION | Sale | 52,397 | 44.68 | 2,341,097 |
| 2026-04-18 | SION | Sale | 2,948 | 44.52 | 131,244 |
| 2026-04-14 | SION | Sale | 47,814 | 44.51 | 2,128,201 |
| 2026-04-15 | SION | Sale | 235,863 | 44.64 | 10,528,924 |
| 2026-04-16 | SION | Sale | 226,906 | 45.34 | 10,287,918 |
| 2026-02-02 | SION | Sale | 1,890 | 44.57 | 84,237 |
| 2026-02-03 | SION | Sale | 29,063 | 44.58 | 1,295,628 |
| 2025-12-24 | SION | Sale | 33,356 | 44.55 | 1,486,009 |
| 2025-12-17 | SION | Sale | 900 | 44.50 | 40,050 |
| 2025-12-18 | SION | Sale | 100 | 44.49 | 4,449 |
| 2025-12-19 | SION | Sale | 875 | 44.49 | 38,928 |
| 2025-11-24 | SION | Sale | 94,583 | 44.54 | 4,212,726 |
| 2025-11-25 | SION | Sale | 11,890 | 44.60 | 530,294 |
| 2025-11-26 | SION | Sale | 1,600 | 44.49 | 71,184 |
| 2025-02-10 | SION | Buy | 550,000 | 18.00 | 9,900,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Orbimed Capital Gp Viii Llc (Officer of Traws Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.